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Introduction 
Lichen sclerosus (LS) is a chronic dermatologic 
condition characterized by atrophic, white-to-
porcelain appearing plaques that can cause intense 
pruritis, discomfort, and soreness [1-3]. These 
plaques are most commonly located in the 
anogenital region in up to 85-98% of cases and affect 
women 6-10 times more frequently than men [2, 3]. 
There is a bimodal age distribution in women with LS 
commonly affecting prepubescent children and 
postmenopausal women. The exact epidemiology of 
LS is unknown, but studies have estimated that one 
in 300-1000 referrals to dermatology clinics are for 
evaluation or management of LS [2]. The 
pathophysiology of the disease is also incompletely 
understood, but it is believed to have underlying 
genetic and autoimmune components [4]. Early in 
the disease, LS has a short inflammatory phase that 
eventually leads to atrophy and scarring. This can 
lead to dysuria, dyspareunia, pain with defecation, 
and loss of architecture depending on the location 
and extent of involvement. Lichen sclerosus induced 
by trauma to the area (Koebner phenomenon) has 
also been noted [2, 3]. Patients with anogenital LS are 
at increased risk for malignancy. In women the risk of 
developing squamous cell carcinoma (SCC) of the 
vulva is around 4-5% and in men there is likely a link 
between LS and penile SCC. However, the exact 
frequency is difficult to establish [2]. Extragenital LS 
is less common, presenting in 15-20% of LS cases, but 
does not appear to have the same association with 
development of malignancy [2, 3]. 
 
Case Synopsis 
Case 1 
Abstract 
Lichen sclerosus (LS) is a chronic dermatologic 
condition characterized by atrophic porcelain-
appearing plaques that can cause intense discomfort 
and eventually lead to destruction of local 
architecture. Lichen sclerosus most commonly arises 
in the anogenital area, but up to 20% of cases can 
present on extragenital skin. Rarely, LS can also 
present with hemorrhage and bullae; the mechanism 
by which this occurs is unknown. We report two cases 
of bullous hemorrhagic LS of the breast arising in 66-
year-old and 77-year-old women. Bullous 
hemorrhagic LS of the breast is exceedingly rare, with 
few reported cases, and presents a diagnostic 
challenge to clinicians. 
 
Figure 1. Bullous hemorrhagic lichen sclerosus. A) Scaly 
violaceous plaque located on the right inferomedial aspect of the 
breast at time of presentation. B) Residual and resolving areas of 
erythema two months after starting twice daily clobetasol 0.05% 
ointment.
A
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A 66-year-old woman with a several-year history of 
biopsy-proven LS of her vulva, abdomen, and breast 
presented to the dermatology clinic as a new patient 
for evaluation of a new hemorrhagic lesion on her 
right breast (Figure 1A). The plaque was pruritic and 
would often bleed. The patient had no history of 
breast cancer but did have bilateral breast reduction 
surgery years prior. Physical examination revealed a 
violaceous scaly plaque on her inferomedial right 
breast. A biopsy of the plaque was performed in-
office and was consistent with the diagnosis of LS 
(Figure 2). Clobetasol 0.05% ointment was 
prescribed for twice-daily use and marked 
improvement was seen at her two-month follow-up 
appointment (Figure 1B). 
Case 2 
A 77-year-old woman with an 11-month history of 
biopsy-proven LS presented to the dermatology 
clinic for evaluation of a tender bleeding “sore” on 
her left breast that had been present for two months. 
She had previously been diagnosed with biopsy 
proven LS of the trunk (Figure 3), vulva, extremities, 
and breast (Figure 4A), which had been treated with 
betamethasone 0.05% cream. The physical 
examination revealed hemorrhagic tense bullae on 
the inferior aspect of the left breast (Figure 4B), 
which was diagnosed as bullous hemorrhagic lichen 
sclerosus based on the clinical history and 
presentation. The patient was advised to start 
clobetasol 0.05% ointment twice daily and the 
plaque showed rapid improvement after three 
weeks (Figure 4C, D). 
 
Case Discussion 
Lichen sclerosus classically presents in the 
anogenital area. However, extragenital lichen 
sclerosus is present in 15-20% of cases and has many 
of the same features as classic anogenital LS. It often 
presents on the trunk, back, axillae, head, neck, 
shoulders, wrist, inner thighs, and inframammary 
area. Extragenital lesions tend not to be as 
symptomatic or pruritic and there is no association 
with malignancy [2, 3]. The treatment of choice for 
both anogenital and extragenital LS is high potency  
B
 
Figure 2. H&E stain revealing epidermal atrophy with a wide 
band of hyalinization as well as a dense lymphohistiocytic 
infiltrate in the superficial dermis. A subepidermal blister with 
extravasated erythrocytes is also present, 200×. 
 
Figure 3. H&E stain from original biopsy of clinically non-bullous 
lichen sclerosus of the chest. The epidermis is missing with 
sclerosis of the upper-mid dermis and associated perivascular 
lymphocytic inflammation, 40×. 
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(Class I) topical corticosteroids [5]. Bullous 
hemorrhagic lichen sclerosus is a rare variant of LS in 
which flaccid bullae develop along with purpuric 
hemorrhages in the skin and these can be found in 
both anogenital or extragenital skin [6]. Despite the 
unique appearance, the prognosis and treatment for 
this variant of LS does not appear to be different from 
that of traditional LS. High potency topical 
corticosteroids have been used to successfully treat 
both anogenital and extragenital bullous 
hemorrhagic LS [6]. The treatment response to high 
potency topical steroids is highlighted in our 
reported cases as each showed rapid improvement 
with the use of clobetasol ointment. 
Bullous hemorrhagic LS of the breast is exceedingly 
rare with very few reports in the literature (Table 1), 
[7-12]. Several of these cases were associated with 
previous radiation treatment for breast cancer and 
two of these cases arose within [9] and concurrently 
[12] with post-irradiation morphea. A separate series 
examining cases of post-irradiation morphea found 
histological evidence of concurrent LS and morphea 
in two of the five cases examined [13]. Several other 
unique cases of LS involving the breast have been 
reported. One unique case involved LS on both 
areolae of a 15-year-old boy, in which the left areola 
had a single small hemorrhagic vesicle but no other 
bullous or hemorrhagic involvement. That case 
could represent the earliest stage of, or a minor case 
of, bullous hemorrhagic LS [14]. Another entity, LS 
with telangiectasias but not hemorrhage or bullae, 
has also been reported. These cases of telangiectatic 
LS appeared after breast irradiation [15, 16]. 
The exact etiology of bullous hemorrhagic LS is 
unknown. One potential explanation for the 
observation that bullae and hemorrhage are so often 
found together has been proposed. Pronounced 
edema within the skin could leave the capillaries 
without surrounding collagen support, thus 
predisposing them to rupture from minimal trauma 
or damage, similar to what is seen in senile and 
corticosteroid induced purpura [17]. A potential 
explanation for the formation of bullae in LS arising 
on irradiated breasts is the alteration of lymphatic 
vessels by radiotherapy. The radiation and 
potentially also the surgical removal of lymph nodes 
could predispose the tissue to edema and bulla  
Table 1. Cases reported for bullous hemorrhagic lichen sclerosus. 
Year  Author & Reference Age/Sex Radiation Comments
1979  Faergemann (7) 68 y F No  Patient also had polymyalgia rheumatica and alopecia totalis 
1993  Starzycki (8) 25 y F No  LS located on both areolae 
1994  Trattner et al. (9) 57 y F Yes  LS arising on pre-existing area of morphea 
2010  Vujovic (10) 77 y F Yes  No pre-existing trauma, radiation, or cancer 
2015  Quatrano et al. (11) 65 y F No  History of breast cancer, but radiation not mentioned 
2018  Petersen et al. (12) 57 y F Yes  LS in superficial dermis, morphea in deep dermis on pathology 
 
Reported cases of bullous hemorrhagic lichen sclerosus (LS) of the breast in the English literature found with the search terms "Bullous 
Hemorrhagic Lichen Sclerosus" and "Lichen Sclerosus Breast" in PubMed. 
The authors declare no conflicts of interests 
 
Figure 4. Progression of lichen sclerosus. A) Previously 
diagnosed lichen sclerosus without hemorrhage. B) Bullous 
hemorrhagic LS at initial visit. C) Bullous hemorrhagic LS after 
one week of clobetasol 0.5% ointment. D) Few remaining areas 
of purpura after three weeks of clobetasol use. 
A B 
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formation [13]. Neither of our reported cases had a 
history of breast cancer or radiation and the patient 
with bilateral breast reduction surgery only had 
unilateral bullous hemorrhagic involvement. Further 
exploration and research are necessary to determine 
the exact mechanisms by which hemorrhagic bullae 
arise in LS. 
 
Conclusion 
Lichen sclerosus is a chronic dermatologic condition 
that typically presents as atrophic porcelain plaques 
in the anogenital region of women. Lichen sclerosus 
can less commonly present in extragenital locations  
and only rarely presents with hemorrhage and 
bullae. The mechanism of hemorrhagic bullae 
formation is not understood but there may be an 
association with radiation therapy and post-
irradiation morphea. Bullous hemorrhagic lichen 
sclerosus of the breast is exceedingly rare, with a 
markedly different clinical appearance than classic 
LS, making it a diagnostic challenge and an 
important entity for clinicians to recognize. 
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